by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Genome
The FDA[1] has just lifted the suspension on clinical trials carried out by the French biotech company, Cellectis, two months after halting proceedings following the death of a patient (see Cellectis forced to suspend gene therapy trials). These...
by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Transhumanism
At the end of October, a humanoid robot was given Saudi nationality (see Humanoid robot awarded Saudi nationality). This week, an android with the features of a small boy became an official resident of Tokyo. For Laetitia Pouliquen, founder of Woman...
by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Embryo research and alternatives
Several American laboratories have apparently inserted human brain organoids into the brains of rats and mice, connecting the two structures via blood vessels. Some of these organoids will develop and scientists believe that human brain tissue could actually work in...
by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Genome
The FDA intends to relax legislation regarding genetic testing in the United States. This is a radical change of direction following the withdrawal of these tests from the market in 2013. Since then, the Agency validates each test annually. The new framework would...
by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Genome
On Wednesday, a medical team announced that surgery performed on a seven year-old boy with a serious hereditary skin disease had been successful. Surgeons reconstituted “80% of his epidermis from genetically modified stem cells” in a world first[1]. ...
by Collectif | 20 Nov, 2017 | Bioethics press synthesis | Prenatal diagnosis
Between April 2015 and August 2016, five UK maternity hospitals/clinics used Non-Invasive Prenatal Screening (NIPS) as part of a research project to test a “reflex” procedure. As a result, “almost 23,000 pregnancies were tested for Down syndrome,...